(63 days)
Not Found
No
The summary describes a mechanical fixation system for ribs and sternum, with no mention of software, algorithms, or any terms related to AI/ML.
Yes
The device is intended to stabilize and provide fixation for conditions like fractures and fusions, which are therapeutic interventions.
No
This device is a surgical implant system designed to stabilize and fix fractures, fusions, and osteotomies of the ribs, and for reconstructions of the chest wall and sternum. It is used for treatment, not for diagnosing conditions.
No
The device description explicitly states it consists of plates and screws made of titanium or titanium alloy, which are hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is for stabilizing and fixing fractures, fusions, osteotomies, and reconstructions of the ribs, chest wall, and sternum. This is a surgical implant used directly on the patient's body.
- Device Description: The description details plates and screws made of titanium or titanium alloy, which are typical components of surgical fixation systems.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens (like blood, urine, or tissue) outside of the body to provide information for diagnosis, monitoring, or screening.
IVD devices are used to perform tests on samples taken from the human body to provide information about a person's health. This device is a physical implant used to repair and stabilize anatomical structures.
N/A
Intended Use / Indications for Use
The ACUTE Innovations® Modular RibLoc System is intended to stabilize and provide fixation for fractures, fusions, and osteotomies of the ribs, and for reconstructions of the chest wall and sternum.
Product codes (comma separated list FDA assigned to the subject device)
HRS, HWC
Device Description
The ACUTE Innovations® Modular RibLoc System consists of plates and screws for fractures, fusions, and osteotomies. The plates are pre-contoured to minimize bending which is done intraoperatively. Instrumentation is supplied with the implants to aid in the insertion of the plates and screws. All plates and screws are manufactured from titanium or titanium alloy.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
ribs, chest wall, sternum
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Preclinical Testing: The non-clinical tests performed by the company include an analysis of strength of the ACUTE Innovations® Modular RibLoc plates. The results of the performed tests demonstrate that the ACUTE Innovations® Modular RibLoc System is substantially equivalent to legally marketed predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.
(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
K113318 '1/2
JAN 1 2 2012
5. 510(k) Summary
| Device Trade Name: | ACUTE Innovations Modular RibLoc Fixation System |
|---|---|
| Manufacturer: | ACUTE Innovations, LLC |
| 21421 NW Jacobson Road, Suite 700 | |
| Hillsboro OR, 20005 | |
| Contact: | Ms. Mariah Knight |
| Regulatory & Quality Manager | |
| 503.686.7200 | |
| Date Prepared: | November 9, 2011 |
| Classifications: | 21 CFR 888.3030, Single/multiple component metallic bone |
| fixation appliances and accessories | |
| and | |
| 21 CFR 888.3040, Smooth or threaded metallic bone fixation | |
| fasteners | |
| Class: | II |
| Product Codes: | HRS and HWC |
Indications for Use:
The ACUTE Innovations® Modular RibLoc System is intended to stabilize and provide fixation for fractures, fusions, and osteotomies of the ribs, and for reconstructions of the chest wall and sternum.
Device Description:
The ACUTE Innovations® Modular RibLoc System consists of plates and screws for fractures, fusions, and osteotomies. The plates are pre-contoured to minimize bending which is done intraoperatively. Instrumentation is supplied with the implants to aid in the insertion of the plates and screws. All plates and screws are manufactured from titanium or titanium alloy.
Predicate Devices:
Comparative information presented in the 510(k) supports the substantial equivalence of the ACUTE Innovations® Modular RibLoc System to the following predicate devices: MedXpert STRATOS (K073556); ACUTE Innovations® RibLoc System (K051410); and ACUTE Innovations Sternal Fixation System (K101170).
1
Substantial Equivalence:
The components of the Acute Innovations® Modular RibLoc System are substantially equivalent to the identified predicates with respect to its indications for use, geometry, available sizes, materials, methods of fixation to bone, and performance.
?
ア
Preclinical Testing:
The non-clinical tests performed by the company include an analysis of strength of the ACUTE Innovations® Modular RibLoc plates. The results of the performed tests demonstrate that the ACUTE Innovations® Modular RibLoc System is substantially equivalent to legally marketed predicate devices.
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features the HHS logo, which is a stylized caduceus, a symbol often associated with medicine and healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the logo.
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002
JAN 1 2 2012
ACUTE Innovations, LLC % Ms. Mariah Knight 21421 NW Jacobson Road, Suite 700 Hillsboro, OR 97124
Re: K113318 Trade/Device Name: ACUTE Innovations Modular RibLoc Fixation System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: II Product Code: HRS, HWC Dated: November 9; 2011 Received: November 10, 2011
Dear Ms. Knight:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
3
Page 2 - Ms. Mariah Knight
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
N.N.B., 1/13/12
Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use 4.
510(k) Number (if known): _K || 3 3 | 8
Device Name: ACUTE Innovations® Modular RibLoc System
The ACUTE Innovations® Modular RibLoc System is intended to stabilize and provide fixation for fractures, fusions, and osteotomies of the ribs, and for reconstructions of the chest wall and sternum.
Prescription Use र्भ (Part 29 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (29 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Elizabethe PR
Co (Division Sign-Oft) Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K113318